drugset / Trial / NCT01111773

Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy

NCT01111773

Phase 2 Completed 13 enrolled ZARS Pharma Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with patellar tendinopathy.

Timeline

Start
2010-06
Primary completion
2011-03
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 70 mg Topical
Subject tetracaine Other / unclassified 70 mg Topical

Indications